These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3395669)

  • 21. Simultaneous determination of acetylsalicylic acid and its major metabolites in human serum by second-derivative synchronous fluorescence spectrometry.
    Konstantianos DG; Ioannou PC
    Analyst; 1992 May; 117(5):877-82. PubMed ID: 1605353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphatic transport of salicylates in dogs.
    Sudo LS; Almeida MG; Yasaka W; Garcia-Leme J
    Gen Pharmacol; 1989; 20(6):779-83. PubMed ID: 2591706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of subchronic parathion administration on sodium salicylate excretion kinetics in female rats.
    Martínez Tabche L; Posadas del Rio FA
    J Appl Toxicol; 1989 Feb; 9(1):5-8. PubMed ID: 2926096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of aspirin and its metabolites in the semen of man.
    Kershaw RA; Mays DC; Bianchine JR; Gerber N
    J Clin Pharmacol; 1987 Apr; 27(4):304-9. PubMed ID: 3680588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects.
    Gatti G; Barzaghi N; Attardo Parrinello G; Vitiello B; Perucca E
    Int J Clin Pharmacol Res; 1989; 9(6):385-9. PubMed ID: 2517497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics in copper deficiency. I. Antiinflammatory activity of aspirin.
    Lopez-Anaya A; Dawson C; Gonzales C; Bacolod M; Kishore V
    Biol Trace Elem Res; 1994 Feb; 40(2):161-76. PubMed ID: 7514021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.
    Miners JO
    Clin Pharmacokinet; 1989 Nov; 17(5):327-44. PubMed ID: 2573442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and determination of salicylic acid and salicyluric acid in urine of people not taking salicylate drugs.
    Baxter GJ; Lawrence JR; Graham AB; Wiles D; Paterson JR
    Ann Clin Biochem; 2002 Jan; 39(Pt 1):50-5. PubMed ID: 11853189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract.
    Schmid B; Kötter I; Heide L
    Eur J Clin Pharmacol; 2001 Aug; 57(5):387-91. PubMed ID: 11599656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous determination of acetylsalicylic and salicylic acids in human serum and aspirin formulations by second-derivative synchronous fluorescence spectrometry.
    Konstantianos DG; Ioannou PC; Efstathiou CE
    Analyst; 1991 Apr; 116(4):373-8. PubMed ID: 1872484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-pass accumulation of salicylic acid in gut tissue after absorption in anesthetized rat.
    Choi YM; Chung SM; Chiou WL
    Pharm Res; 1995 Sep; 12(9):1323-7. PubMed ID: 8570529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
    Montgomery PR; Sitar DS
    Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
    Roberts MS; McLeod LJ; Cossum PA; Vial JH
    Eur J Clin Pharmacol; 1984; 27(1):67-74. PubMed ID: 6436031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady-state levels of salicylic acid and its metabolites in plasma and urine.
    Edgar B; Bogentoft C; Lagerström PO
    Biopharm Drug Dispos; 1984; 5(3):251-60. PubMed ID: 6541512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease.
    Koren G; MacLeod SM
    J Pediatr; 1984 Dec; 105(6):991-5. PubMed ID: 6502354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the reactivity of acyl glucuronides--VII. Salicyl acyl glucuronide reactivity in vitro and covalent binding of salicylic acid to plasma protein of humans taking aspirin.
    Dickinson RG; Baker PV; King AR
    Biochem Pharmacol; 1994 Feb; 47(3):469-76. PubMed ID: 8117314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.
    Graham GG; Champion GD; Day RO; Paull PD
    Clin Pharmacol Ther; 1977 Oct; 22(4):410-20. PubMed ID: 902454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of single-dose intravenous and oral aspirin in children.
    Ito S; Oka R; Tsuchida A; Yoshioka H
    Dev Pharmacol Ther; 1991; 17(3-4):180-6. PubMed ID: 1841835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdose.
    Patel DK; Ogunbona A; Notarianni LJ; Bennett PN
    Hum Exp Toxicol; 1990 Nov; 9(6):389-95. PubMed ID: 2271231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrolysis of salicyluric acid in rabbit intestinal microorganisms.
    Shibasaki J; Inoue Y; Kadosaki K; Sasaki H; Nakamura J
    J Pharmacobiodyn; 1985 Dec; 8(12):989-95. PubMed ID: 3834062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.